FDA Clears Vagus Nerve Stimulator for Migraine Pain
FDA Clears Vagus Nerve Stimulator for Migraine Pain
The FDA has expanded the label for the gammaCore vagus nerve stimulator to include treatment of acute pain from migraine in addition to the previously cleared treatment of episodic cluster headache.
Frontiers Therapeutic applications of transcutaneous auricular vagus nerve stimulation with potential for application in neurodevelopmental or other pediatric disorders
Nerve Stimulation Devices for Migraine Treatment
Todd Charnetski on LinkedIn: This vagus nerve stimulation technology is amazing for headache prevention…
Research Supports Key Areas Of Clinical Development For ElectroCore's Vagus Nerve Stimulator
Migraine Treatments What Options Do You Have?
New Device May End Pain for Veterans Suffering from PTSD and TBI-Related Headaches
electroCore Receives 510(k) Clearance for gammaCore-S® (non-invasive vagus nerve stimulator) for the Acute Treatment of Pain Associated with Episodic Cluster Headache in Adult Patients - electroCore
Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review - ScienceDirect
A partial solution for migraines and PTSD? This approach offers hope.
